Arkema Shares Gain 1% at Close, Driven by a Technical Rebound
Arkema's stock ended Wednesday up 1.08% at 51.25 euros. This increase follows a 5.76% rise over the last seven days, even as the specialty chemicals group remains hampered by a 34% decline over twelve months.
Current Stock Performance
Arkema's stock price is now at 51.25 euros, above its previous closing level of 50.70 euros. Over the week, the stock has increased by nearly 6%, a movement reflecting a renewed interest after a marked downward trend over three months, with a decline of 2.57%. The 14-period RSI stands at 44, indicating a neutral market without overbuying or overselling. The 20-day moving average is at 51.80 euros, slightly above the current price, signaling proximity to a short-term technical resistance zone. The one-month volatility is at 10.39, indicating a moderate amplitude of recent fluctuations. These elements confirm a market stabilizing after the past year's turbulence.
Analyst Opinions Remain Mixed
Analyst opinions on Arkema remain divided. UBS maintains a 'buy' recommendation, with a price target reduced from 64 to 61 euros on January 14, implying an upside potential of nearly 19% compared to the current price. Conversely, Bernstein remains cautious: on January 20, the bank reiterated its underperformance advice and lowered its target from 49 to 47 euros, suggesting a downside risk of 8% from Wednesday's closing level. These differing assessments illustrate the difficulty in evaluating the chemist's prospects in a contrasting sectoral context. The annual performance of -34% continues to weigh on the overall assessment, but the recent rebound indicates that some investors consider the stock undervalued.
